A Study of Epinastine Nasal Spray in Subjects With Seasonal Allergic Rhinitis
| Status: | Completed |
|---|---|
| Conditions: | Allergy |
| Therapuetic Areas: | Otolaryngology |
| Healthy: | No |
| Age Range: | 12 - Any |
| Updated: | 4/21/2016 |
| Start Date: | December 2006 |
| End Date: | March 2007 |
A Randomized, Multi-Center, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Ranging Safety, Efficacy, and Tolerability Study of Two Doses of Epinastine Nasal Spray (0.05% and 0.1%) vs. Placebo in Subjects With Seasonal Allergic Rhinitis
The purpose of this trial is to determine the safety, efficacy and tolerability of two doses
of the study drug compared to placebo for the treatment of subjects with seasonal allergic
rhinitis.
of the study drug compared to placebo for the treatment of subjects with seasonal allergic
rhinitis.
Inclusion Criteria:
- A documented history of seasonal allergic rhinitis to mountain cedar pollen
Exclusion Criteria:
- Significant medical condition
- Cardiovascular abnormality
- Have a significant physical obstruction in the nose
- Started or had a change in immunotherapy within the 30 days prior to
screening
- Have nasal ulceration(s) or any active nasal bleeding
- Require use of allergy medications during the study
- Require use of asthma medications other than as needed albuterol
We found this trial at
7
sites
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials